The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).

The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction). JACC Heart Fail. 2015 Jun; 3(6):429-441.

View in: PubMed

subject areas

Aged
Female
Heart Failure
Hospitalization
Humans
Male
Prognosis
Proportional Hazards Models
Risk Factors
Stroke Volume

authors with profiles

Michael R. Zile